middle.news
Neurizon Breaks FDA Hold, Secures $33M to Fast-Track ALS Drug NUZ-001
9:13am on Friday 30th of January, 2026 AEDT
•
Biotechnology
Read Story
Neurizon Breaks FDA Hold, Secures $33M to Fast-Track ALS Drug NUZ-001
9:13am on Friday 30th of January, 2026 AEDT
Key Points
FDA lifts clinical hold on NUZ-001 IND application
NUZ-001 cleared for HEALEY ALS Platform Trial entry as Regimen I
Australian patent granted extending IP protection to 2041
$33 million funding package secured including placement, entitlement offer, and convertible note
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NUZ
OPEN ARTICLE